Richard A. Larson to Bendamustine Hydrochloride
This is a "connection" page, showing publications Richard A. Larson has written about Bendamustine Hydrochloride.
Connection Strength
0.222
-
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL. N Engl J Med. 2018 12 27; 379(26):2517-2528.
Score: 0.171
-
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202. Leukemia. 2021 10; 35(10):2854-2861.
Score: 0.051